MYSTERIOUS: J j | Mind Blowing Facts

J&J's Once-Daily Icotyde Pill Eased Psoriatic Arthritis Joint Symptoms in 58% of Patients Versus 41% on Placebo

In a Phase 3 trial, daily icotrokinra improved joint and skin symptoms versus placebo in psoriatic arthritis, though the drug is not yet approved for the condition.

Medical Daily · 6h ago

Dear Johnson & Johnson Stock Fans, Mark Your Calendars for October 13

Johnson & Johnson will report its third-quarter results on Oct. 13.

Barchart · Oct 11

Vacunados con J&J, reforzados con ARNm, y pensando en la tercera dosis

Sí, todos estamos agotados por la pandemia de covid. Desconcertados por los constantes cambios en la ciencia y en las directrices. Preocupados por la sucesión de nuevas y temibles variantes, cada una con su propio nombre, como los huracanes.

Tribune News Service · Mar 9, 2022

J&J, distributors finalize $26B landmark opioid settlement

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis

The Independent UK · Feb 25, 2022

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel In Late March

Benzinga · Feb 17, 2022

Vaccinated people less likely to get long Covid than unvaccinated, new study shows

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

The Independent UK · Feb 15, 2022

J&J starts trial on bankruptcy case under attack by Congress

The controversial Johnson & Johnson bankruptcy strategy that’s drawn the ire of Congress faces a fresh trial this week, with the consumer products giant arguing that settling billions of dollars of talc liabilities in a single case is better for cancer victims than fighting thousands of individual claims.

Tribune News Service · Feb 14, 2022

Johnson & Johnson faces push to force global ban on talc baby powder sales

Move to hold shareholder vote follows withdrawal of product in US and Canada and lawsuits alleging link to cancer cases

The Guardian - UK · Feb 6, 2022

Johnson & Johnson recipients can get third COVID shot in San Francisco

SAN FRANCISCO — San Francisco health officials are allowing people who originally got the Johnson & Johnson COVID-19 vaccine to get a second booster shot — which would give them access to the same number of doses currently available to recipients of Pfizer-BioNTech or Moderna.

Los Angeles Times · Feb 2, 2022

The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jan 27, 2022